Invention Grant
US08343943B2 Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof
失效
包含葡糖胺，葡糖胺衍生物或其盐的癌症敏化剂
- Patent Title: Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof
- Patent Title (中): 包含葡糖胺，葡糖胺衍生物或其盐的癌症敏化剂
-
Application No.: US12438914Application Date: 2006-12-06
-
Publication No.: US08343943B2Publication Date: 2013-01-01
- Inventor: Soo Youl Kim , Dae Seok Kim
- Applicant: Soo Youl Kim , Dae Seok Kim
- Applicant Address: KR Goyang-Si
- Assignee: National Cancer Center
- Current Assignee: National Cancer Center
- Current Assignee Address: KR Goyang-Si
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: KR10-2006-0054519 20060616; KR10-2006-0119620 20061130
- International Application: PCT/KR2006/005229 WO 20061206
- International Announcement: WO2007/145405 WO 20071221
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A01N43/16 ; A61K31/70 ; A61K31/35 ; C07D315/00
Abstract:
Disclosed herein is a cancer sensitizer comprising glucosamine, a glucosamine derivative, or a salt thereof. When administered to patients with cancer, the cancer sensitizer functions to sensitize cancer cells to anticancer agents without producing side effects, thereby increasing the therapeutic efficiency of chemotherapy.
Public/Granted literature
- US20100016249A1 CANCER SENSITIZER COMPRISING GLUCOSAMINE, GLUCOSAMINE DERIVATIVES OR SALTS THEREOF Public/Granted day:2010-01-21
Information query
IPC分类:
